nejm semaglutide cardiovascular In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist was effective in preventing progression of kidney disease in patients with type 2 diabetes and chronic kidney disease Cardiovascular outcomes of semaglutide and
Description
Conclusions/interpretation These results suggest that CB1R could be an interesting target for type 1 diabetes while highlighting the regulatory mechanisms of insulitis
Find out why Tupelo, MS is a great place to live.
Free telemedicine consults!
Understand how this GLP-1 receptor agonist works, dosing, and side effects
Creatine - Supports muscle strength and helps prevent muscle loss during calorie deficits
Collagen supplementation alongside semaglutide is generally considered safe, though timing, protein intake balance, and individual gastrointestinal tolerance warrant careful provider discussion
